Related references
Note: Only part of the references are listed.Alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase activity in the sera of patients with esophageal cancer
Wojciech Jelski et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2009)
The Functional-Organic Dichotomy: Postinfectious Irritable Bowel Syndrome and Inflammatory Bowel Disease-Irritable Bowel Syndrome
Madhusudan Grover et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: Performance of fecal lactoferrin, calprotectin, and PMN-Elastase, CRP, and clinical indices
Jost Langhorst et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome
Charlotte M. T. Otten et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2008)
Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome
Jeroen Aerssens et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Review of fecal biomarkers in inflammatory bowel disease
Andrew D. Sutherland et al.
DISEASES OF THE COLON & RECTUM (2008)
Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases
Charles N. Bernstein et al.
GUT (2008)
Crohn's disease: factors associated with exposure to high levels of diagnostic radiation
A. N. Desmond et al.
GUT (2008)
Population-based controlled study of social support, self perceived stress, activity and work issues, and access to health care in inflammatory bowel disease
Linda Rogala et al.
INFLAMMATORY BOWEL DISEASES (2008)
Discriminating IBD from IBS: Comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies
Alain M. Schoepfer et al.
INFLAMMATORY BOWEL DISEASES (2008)
Antibodies to flagellin indicate reactivity to bacterial antigens in IBS patients
A. M. Schoepfer et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2008)
Immune activation in patients with irritable bowel syndrome
Tobias Liebregts et al.
GASTROENTEROLOGY (2007)
A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis
Geert D'Haens et al.
GASTROENTEROLOGY (2007)
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications
J. Satsangi et al.
GUT (2006)
Oratory markers in IBD: Magic, or unneccessary toys?
S Vermeire et al.
GUT (2006)
Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: Plasma cytokines as a potential biomarker?
TG Dinan et al.
GASTROENTEROLOGY (2006)
Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact
APS Hungin et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Lactobacillus and Bifidobacterium in irritable bowel syndrome:: Symptom responses and relationship to cytokine profiles
L O'Mahony et al.
GASTROENTEROLOGY (2005)
Changes in enteric neural circuitry and smooth muscle in the inflamed and infected gut
GM Mawe et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2004)
IBS-like symptoms in patients with inflammatory bowel disease in remission; Relationships with quality of life and coping behavior
IM Minderhoud et al.
DIGESTIVE DISEASES AND SCIENCES (2004)
The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects
APS Hungin et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
The impact of duration of GERD symptoms on severity of esophagitis and response to treatment with esomeprazole or lansoprazole
MB Fennerty et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2002)
Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease
JA Tibble et al.
GASTROENTEROLOGY (2002)
Health-related quality of life and health care costs in severe, refractory irritable bowel syndrome
F Creed et al.
ANNALS OF INTERNAL MEDICINE (2001)
A simple method for assessing intestinal inflammation in Crohn's disease
J Tibble et al.
GUT (2000)
Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease
JA Tibble et al.
GASTROENTEROLOGY (2000)
Share Paper
